Mirae Asset Global Investments
STOK icon

Mirae Asset Global Investments’s Stoke Therapeutics STOK Stock Holding History

Mirae Asset Global Investments’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.1K Sell
2,785
-194
-7% -$6.23K ﹤0.01% 1253
2026
Q1 		$97K Buy
2,979
+203
+7% +$6.66K ﹤0.01% 1187
2025
Q4 		$88.1K Buy
2,776
+658
+31% +$19.8K ﹤0.01% 1285
2025
Q3 		$49.8K Buy
2,118
+9
+0.4% +$154 ﹤0.01% 1340
2025
Q2 		$23.9K Buy
2,109
+322
+18% +$3.06K ﹤0.01% 1371
2025
Q1 		$12.9K Buy
1,787
+22
+1% +$205 ﹤0.01% 1444
2024
Q4 		$19.5K Buy
+1,765
New +$21.7K ﹤0.01% 1426
2024
Q2 		– Sell
-90,663
Closed -$728K – 2415
2024
Q1 		$728K Buy
+90,663
New +$549K ﹤0.01% 1708
2023
Q4 		– Sell
-146,076
Closed -$576K – 2596
2023
Q3 		$576K Buy
146,076
+12,478
+9% +$82K ﹤0.01% 1811
2023
Q2 		$1.42M Buy
133,598
+41,242
+45% +$439K ﹤0.01% 1383
2023
Q1 		$769K Buy
92,356
+741
+0.8% +$6.68K ﹤0.01% 1679
2022
Q4 		$846K Sell
91,615
-2,738
-3% -$28.5K ﹤0.01% 1584
2022
Q3 		$1.21M Buy
94,353
+13,555
+17% +$216K ﹤0.01% 1383
2022
Q2 		$1.07M Buy
+80,798
New +$1.23M ﹤0.01% 1372

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mirae Asset Global Investments's STOK Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Stoke Therapeutics (STOK) stake by 6.5% in Q2 2026, selling an estimated $6.23K and leaving 2,785 shares worth $91.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Mirae Asset Global Investments first reported a position in STOK in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.42M in Q2 2023. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Mirae Asset Global Investments held 2,785 shares of Stoke Therapeutics worth $91.1K as of Q2 2026.
  • Mirae Asset Global Investments sold 194 Stoke Therapeutics shares in Q2 2026, an estimated $6.23K.
  • Stoke Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1253 holding.
  • Mirae Asset Global Investments first reported a position in Stoke Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Mirae Asset Global Investments's Stoke Therapeutics position peaked at $1.42M in Q2 2023.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.